**To the Editor,**

The recent letter by Drs Mungmunpuntipantipand Wiwanitkit[@CR1] argues that our report about chest computed tomography (CT) findings in a pregnant woman with coronavirus disease (COVID-19)[@CR2] are inconsistent with "early" COVID-19. In doing so, they discourage the consideration of CT findings when ruling out cases of COVID-19. Nevertheless, we think that their concern may have be guided by an incomplete understanding of the COVID-19 epidemic. As of 17 March 2020, more than 50,000 people have been confirmed with COVID-19 in Wuhan. During the period of the most severe increases in COVID-19 cases, the supply of nucleic acid detection kits could not meet the demands of the sharp increase in COVID-19 patients. So the diagnosis of COVID-19 followed the New Coronavirus Pneumonia Prevention and Control Program (fifthedition)[1](#Fn1){ref-type="fn"} issued by the National Health Commission of China that took "suspected cases with pneumonia imaging features" as the clinical diagnosis case standard in Hubei Province. This allowed more COVID-19 patients to receive more timely treatment.

In earlier stages of the disease progression, the changes of chest CT scan were mainly congestion, edema, and exudation. For example, Shi *et al.* reported that "COVID-19 manifests with chest CT imaging abnormalities, even in asymptomatic patients, with rapid evolution from focal unilateral to diffuse bilateral ground-glass opacities that progressed to or co-existed with consolidations".[@CR3] It is worth noting that only a single ground-glass opacity can be seen in some patients at an early stage, and the range significantly increases in the short-term re-examination.[@CR4] When a patient's condition improves, a few fibrous streaks may appear. On the contrary, when the condition is more advanced, diffuse lesions appear in the lungs, and the density of both lungs increases, showing a "white lung", which seriously affects the patient's lung function.[@CR4]

Importantly, all diagnostic methods have disadvantages. In China, 29.2% of asymptomatic patients who were found to be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and presented with either no or mild symptoms at the time of diagnosis by real-time reverse-transcriptionpolymerase chain reaction (RT-PCR) test had a normal chest CT scan.[@CR5] In addition, there were also some patients with positive chest CT findings who presented with a negative RT-PCR for SARS-CoV-2.[@CR6] Ai *et al*. showed that 60--93% of cases had an initial positive CT consistent with COVID-19 prior to (or parallel with) the initial positive RT-PCR results. Forty-two percent (24/57) of cases showed improvement in follow-up chest CT scans before the RT-PCR results turned negative.[@CR7] Thus, chest CT may still be considered as one of the primary tools for detecting COVID-19 in epidemic areas.

We therefore still suggest that the combined assessment of CT imaging features with clinical and laboratory findings could facilitate diagnosis of COVID-19 earlier and more accurately. This may also help curb the spread of the COVID-19 pandemic.
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